Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells

被引:54
|
作者
Matthews, CC
Odeh, HM
Feldman, EL
机构
[1] UNIV MICHIGAN, DEPT NEUROL, ANN ARBOR, MI 48109 USA
[2] UNIV MICHIGAN, PROGRAM NEUROSCI, ANN ARBOR, MI 48109 USA
关键词
IGF-I; programmed cell death; neuroblastoma; osmoprotection; proteases;
D O I
10.1016/S0306-4522(96)00611-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A role in neuronal homeostasis is suggested by the persistent expression of the insulin-like growth factors in the adult nervous system. SH-SY5Y human neuroblastoma cells, a well-characterized in vitro model of human neurons, were used to investigate the effects of hyperosmotic stress on neurons. Neuronal DNA fragmentation was detected within 1 h and pyknotic nuclei were apparent in attached cells after 12 h of hyperosmotic stress. In parallel, flow cytometry measurements revealed a sudden increase in the rate of cells irreversibly undergoing programmed cell death after 12 h of hyperosmotic exposure. Insulin-like growth factor-I delayed the onset of a laddered DNA fragmentation pattern for 24 h and provided continuing protection against hyperosmotic exposure for 72 h. Amino acid uptake was decreased in hyperosmotic medium even in the presence of insulin-like growth factor-I; the protein synthesis inhibitor cycroheximide neither prevented the induction of programmed cell death nor interfered with the ability of insulin-like growth factor-I to act as an osmoprotectant in hyperosmotic medium. Cysteine and serine protease inhibitors each prevented DNA fragmentation under hyperosmotic conditions, suggesting that the osmoprotectant activity of insulin-like growth factor-I involves the suppression of protease activity. Collectively, these results indicate that insulin-like growth factor-I limits the death of neurons under stressful environmental conditions, suggesting that it may provide a candidate therapy in the treatment of hyperosmolar coupled neurological injury. (C) 1997 IBRO.
引用
收藏
页码:525 / 534
页数:10
相关论文
共 50 条
  • [1] Insulin-like growth factor-I signaling in human neuroblastoma cells
    Bhumsoo Kim
    Cynthia M van Golen
    Eva L Feldman
    [J]. Oncogene, 2004, 23 : 130 - 141
  • [2] Insulin-like growth factor-I signaling in human neuroblastoma cells
    Kim, B
    van Golen, CM
    Feldman, EL
    [J]. ONCOGENE, 2004, 23 (01) : 130 - 141
  • [3] INSULIN-LIKE GROWTH FACTOR-I IS A SERUM COMPONENT STIMULATING GROWTH OF HUMAN NEUROBLASTOMA
    BURKE, TW
    VUKPAVLOVIC, S
    [J]. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 1993, 29A (05) : 391 - 394
  • [4] Insulin-like growth factor-I prevents mitochondrial membrane depolarization in neuroblastoma cells
    van Golen, CM
    Feldman, EL
    [J]. NEUROLOGY, 1999, 52 (06) : A425 - A425
  • [5] Insulin-like growth factor I stimulates motility in human neuroblastoma cells
    Meyer, GE
    Shelden, E
    Kim, B
    Feldman, EL
    [J]. ONCOGENE, 2001, 20 (51) : 7542 - 7550
  • [6] Insulin-like growth factor I stimulates motility in human neuroblastoma cells
    Gary E Meyer
    Eric Shelden
    Bhumsoo Kim
    Eva L Feldman
    [J]. Oncogene, 2001, 20 : 7542 - 7550
  • [7] INSULIN-LIKE GROWTH FACTOR-I SYNTHESIS BY HUMAN GLOMERULAR MESANGIAL CELLS
    ARON, DC
    HOUT, WM
    ABBOUD, HE
    [J]. KIDNEY INTERNATIONAL, 1989, 35 (01) : 308 - 308
  • [8] DEMONSTRATION OF INSULIN-LIKE GROWTH FACTOR-I RECEPTOR IN HUMAN CHORIOCARCINOMA CELLS
    RITVOS, O
    RANTA, T
    RUTANEN, EM
    [J]. ANTICANCER RESEARCH, 1986, 6 (03) : 385 - 385
  • [9] Microdialysis of insulin-like growth factor-I in human muscle
    N. Desvigne
    J. C. Barthélémy
    D. Frère
    J. P. Gay-Montchamp
    F. Costes
    [J]. European Journal of Applied Physiology, 2005, 94 : 216 - 219
  • [10] Microdialysis of insulin-like growth factor-I in human muscle
    Desvigne, N
    Barthélémy, JC
    Frère, D
    Gay-Montchamp, JP
    Costes, F
    [J]. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2005, 94 (1-2) : 216 - 219